Align Technology, Inc.
ALGNNASDAQHealthcareMedical Instruments & Supplies
As of Oct 23, 2026 close
- Market cap
- $11.12B
- P/E (TTM)
- 26.89
- Forward P/E
- 28.58
- Dividend yield
- -
- 52-week range
- $130.23$200.44
- Volume (live)
- -
- Avg. volume (3M)
- 953.71K
Align Technology (ALGN) Stock Price & Financial Analysis
Align Technology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $152.70 - $155.80 |
|---|---|
| 52-Week High | $200.44 |
| 52-Week Low | $130.23 |
| Open | $154.79 |
| Volume (last close) | 911.57K |
| Average Volume (3M) | 953.71K |
| Revenue (TTM) | 4.14B |
|---|---|
| Net Income (TTM) | 413.58M |
| Free Cash Flow (TTM) | 736.01M |
| EPS (TTM) | $5.76 |
| Profit Margin | 9.99% |
| Operating Margin | 14.08% |
| Return on Equity (ROE) | 9.77% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 11.12B |
|---|---|
| Shares Outstanding | 71.52M |
| P/E Ratio (TTM) | 26.89 |
| Forward P/E | 28.58 |
| Price to Sales (P/S) | 2.69 |
| Price to Book (P/B) | 2.63 |
| EV/EBITDA | 11.53 |
| 50-Day MA | $153.31 |
|---|---|
| 200-Day MA | $169.45 |
| 1-Year Change | +14.35% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Align Technology at a Glance
As of the Oct 23, 2026 close, Align Technology (ALGN) has a market capitalization of $11.12B. The stock trades at 26.9× trailing earnings, 28.6× forward earnings and 2.7× sales. Over the trailing twelve months it earned $413.58M on revenue of $4.14B (a 10.0% profit margin) and generated $736.01M of free cash flow. Revenue grew 4.4% year over year.
As of its latest reported balance sheet, it holds $1.10B in cash and securities against $120.84M of debt, a net cash position of $981.75M.
Align Technology does not currently pay a dividend.
The share price is up 14.3% over the past year. At $154.51 (the Oct 23, 2026 close) it sits within its 52-week range of $130.23 to $200.44, below its 200-day moving average of $169.45.
Based on 15 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $197.67, 27.9% above the Oct 23, 2026 close.
Frequently Asked Questions About Align Technology
What is the current stock price for ALGN?
As of the Oct 23, 2026 close, ALGN stock trades at $154.51. The 52-week range is $130.23–$200.44, with a day range of $152.70–$155.80.
What is the P/E ratio for ALGN?
As of the Oct 23, 2026 close, Align Technology's trailing twelve-month (TTM) P/E ratio is 26.9, meaning investors pay $26.9 for every $1 of annual earnings. The forward P/E is 28.6, reflecting analyst expectations for future earnings. Align Technology operates in the Healthcare sector.
Does ALGN pay dividends?
Align Technology does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ALGN?
Based on ratings from 15 professional analysts over the last 90 days, the consensus for ALGN is Buy. The average 12-month price target is $197.67, a 27.9% upside from the Oct 23, 2026 close of $154.51.
What is the market cap of ALGN?
As of the Oct 23, 2026 close, Align Technology's market capitalization is $11.05B, classifying it as a large-cap company. Align Technology operates in the Healthcare sector within the Medical Instruments & Supplies industry.